Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.60T
24h Vol:
$4.13B
Dominance:
MSFT:5.14%
Stocklytics Platform
BETA
Instrument logo  NAMSW

NewAmsterdam Pharma Company N.V.

NAMSW
5 / 100
$11.81arrow_drop_up1.37%$0.16

Performance History

Stocklytics logo
Key Stats
Open$12.00
Prev. Close$11.65
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range11.81
12.00
52 Week Range0.99
14.67
Ratios
P/B Ratio0.00
Revenue$97.50M
Operating M. %-805.76%
Earnings$0.00
Earnings Growth %-172.92%
EBITDA Margin %-141.15%
ROE %-68.46%
EPS-

Score Breakdown

5vs 53. Market Avg.

All Score 5 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

NAMSWMARKET
Value039
Quality040
Ownership019
Growth1446
Dividends-37

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$323.88
24H (%)arrow_drop_up0.55%
24H ($)$1.79
MARKET CAP$161.73B
PRICE$376.64
24H (%)arrow_drop_down-1.67%
24H ($)-$6.39
MARKET CAP$52.45B
PRICE$24.45
24H (%)arrow_drop_up0.41%
24H ($)$0.10
MARKET CAP$37.90B
PRICE$23.15
24H (%)arrow_drop_up0.25%
24H ($)$0.06
MARKET CAP$36.41B

About NewAmsterdam Pharma Company N.V. (NAMSW)

No data available
Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NASDAQ
add NewAmsterdam Pharma Company N.V. to watchlist

Keep an eye on NewAmsterdam Pharma Company N.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is NewAmsterdam Pharma Company N.V.'s (NAMSW) price per share?

The current price per share for NewAmsterdam Pharma Company N.V. (NAMSW) is $11.65. The stock has seen a price change of $1.59 recently, indicating a 15.81% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for NewAmsterdam Pharma Company N.V. (NAMSW)?

For NewAmsterdam Pharma Company N.V. (NAMSW), the 52-week high is $14.67, which is 25.92% from the current price. The 52-week low is $0.99, the current price is 1.08K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is NewAmsterdam Pharma Company N.V. (NAMSW) a growth stock?

NewAmsterdam Pharma Company N.V. (NAMSW) has shown an average price growth of over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NewAmsterdam Pharma Company N.V. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is NewAmsterdam Pharma Company N.V. (NAMSW) stock price performance year to date (YTD)?

As of the latest data, NewAmsterdam Pharma Company N.V. (NAMSW) has a year-to-date price change of 281.97%. Over the past month, the stock has experienced a price change of -6.28%. Over the last three months, the change has been 439.35%.

question_mark
Is NewAmsterdam Pharma Company N.V. (NAMSW) a profitable company?

NewAmsterdam Pharma Company N.V. (NAMSW) has a net income of -$78.05M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 100% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -805.76% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $97.5M, although specific revenue growth data is currently not available. The gross profit is $97.5M. Operating income is noted at -$67.56M. Furthermore, the EBITDA is -$148.92M.

question_mark
What is the market capitalization of NewAmsterdam Pharma Company N.V. (NAMSW)?

NewAmsterdam Pharma Company N.V. (NAMSW) has a market capitalization of . The average daily trading volume is 7.28K, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.